Xanthine oxidoreductase gene polymorphisms are associated with high risk of sepsis and organ failure

  • Nicholas Rafaels (Creator)
  • Tanda M. Dudenkov (Creator)
  • Mahendra Damarla (Creator)
  • Rachel Damico (Creator)
  • Marc Moss (Creator)
  • Greg S. Martin (Creator)
  • Jonathan E. Sevransky (Creator)
  • Carl Shanholtz (Creator)
  • Dan Herr (Creator)
  • Joe GN Garcia (Creator)
  • Tamara Hernández-Beeftink (Creator)
  • Jesus Villar (Creator)
  • Carlos Flores (Creator)
  • Terri H. Beaty (Creator)
  • Roy G. Brower (Creator)
  • Paul M. Hassoun (Creator)
  • Kathleen C. Barnes (Creator)



Abstract Background Sepsis and associated organ failures confer substantial morbidity and mortality. Xanthine oxidoreductase (XOR) is implicated in the development of tissue oxidative damage in a wide variety of respiratory and cardiovascular disorders including sepsis and sepsis-associated acute respiratory distress syndrome (ARDS). We examined whether single nucleotide polymorphisms (SNPs) in the XDH gene (encoding XOR) might influence susceptibility to and outcome in patients with sepsis. Methods We genotyped 28 tag SNPs in XDH gene in the CELEG cohort, including 621 European American (EA) and 353 African American (AA) sepsis patients. Serum XOR activity was measured in a subset of CELEG subjects. Additionally, we assessed the functional effects of XDH variants utilizing empirical data from different integrated software tools and datasets. Results Among AA patients, six intronic variants (rs206805, rs513311, rs185925, rs561525, rs2163059, rs13387204), in a region enriched with regulatory elements, were associated with risk of sepsis (P 
Date made available2023

Cite this